November 2, 10:50 AM
CytoSorbents (NASDAQ:CTSO) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that CytoSorbents will report an earnings per share (EPS) of $-0.16.
October 6, 11:12 AM
The U.S. Army Medical Research Acquisition Activity has awarded CytoSorbents Corp (NASDAQ:CTSO) a three-year Phase 3 contract valued at $4.3 million for…
CytoSorbents Awarded An ~$4.3M Contract By The U.S. Department Of Defense To Develop HemoDefend-BGA For Freeze-Dried Universal Plasma
October 6, 7:02 AM
CytoSorbents Corporation (NASDAQ:CTSO), a critical care immunotherapy leader specializing in blood purification, announced today that the U.S. Army Medical Research Acquisition Activity (USAMRAA) has awarded
August 17, 7:22 AM
PRINCETON, N.J., Aug. 17, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via
June 23, 4:25 AM
Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares climbed 117.2% to close at $12.86 on Wednesday after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.